UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry

Arthritis research & therapy, 2017-11, Vol.19 (1), p.256-256, Article 256

2017

Volltextzugriff (PDF)

Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry

Arthritis research & therapy, 2020-10, Vol.22 (1), p.1-258, Article 258

2020

Volltextzugriff (PDF)

Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany

Arthritis research & therapy, 2020-04, Vol.22 (1), p.81-81, Article 81

2020

Volltextzugriff (PDF)

Baricitinib in therapy of COPA syndrome in a 15-year-old girl

European journal of rheumatology, 2020-02, Vol.7 (Suppl1), p.S78-81

2020

Volltextzugriff (PDF)

Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry

Rheumatology international, 2021-04, Vol.41 (4), p.751-762

2021

Volltextzugriff (PDF)

Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohort

Arthritis research & therapy, 2018-12, Vol.20 (1), p.276-276, Article 276

2018

Volltextzugriff (PDF)

The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON)

Arthritis research & therapy, 2018-05, Vol.20 (1), p.106-106, Article 106

2018

Volltextzugriff (PDF)

Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still's disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity

BMC rheumatology, 2019-01, Vol.3 (1), p.4-4, Article 4

2019

Volltextzugriff (PDF)

Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis

Arthritis research & therapy, 2021-04, Vol.23 (1), p.118-118, Article 118

2021

Volltextzugriff (PDF)

Outcome of adult patients with JIA treated with the biosimilar Benepali ® : results of the biologic register JuMBO

Arthritis research & therapy, 2022-12, Vol.24 (1), p.271-271, Article 271

2022

Volltextzugriff (PDF)

Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial

Arthritis research & therapy, 2019-05, Vol.21 (1), p.125-125, Article 125

2019

Volltextzugriff (PDF)

Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry

Arthritis care & research (2010), 2017-04, Vol.69 (4), p.552-560

2017

Volltextzugriff (PDF)

Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study

Pediatric rheumatology online journal, 2022-11, Vol.20 (1), p.100-100, Article 100

2022

Volltextzugriff (PDF)

Fluorescence optical imaging in pediatric patients with inflammatory and non-inflammatory joint diseases: a comparative study with ultrasonography

Arthritis research & therapy, 2017-10, Vol.19 (1), p.233-233, Article 233

2017

Volltextzugriff (PDF)

Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review

Pediatric rheumatology online journal, 2023-02, Vol.21 (1), p.20-20, Article 20

2023

Volltextzugriff (PDF)

S2k guidelines for the treatment of psoriasis in children and adolescents – Short version part 2

Journal der Deutschen Dermatologischen Gesellschaft, 2019-09, Vol.17 (9), p.959-973

2019

Volltextzugriff (PDF)

Protocols on classification, monitoring and therapy in children's rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis

Pediatric rheumatology online journal, 2017-11, Vol.15 (1), p.78-78, Article 78

2017

Volltextzugriff (PDF)

Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany

Rheumatic & musculoskeletal diseases open, 2021-07, Vol.7 (2), p.e001687

2021

Volltextzugriff (PDF)

Level and correlates of physical activity among children and adolescents with juvenile idiopathic arthritis compared to controls: results from a German nationwide prospective observational cohort study

Pediatric rheumatology online journal, 2024-03, Vol.22 (1), p.39-39, Article 39

2024

Volltextzugriff (PDF)

Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial

Pediatric rheumatology online journal, 2021-01, Vol.19 (1), p.5-5, Article 5

2021

Volltextzugriff (PDF)

Fluorescence optical imaging and musculoskeletal ultrasonography in juvenile idiopathic polyarticular disease before and during antirheumatic treatment - a multicenter non-interventional diagnostic evaluation

Arthritis research & therapy, 2017-06, Vol.19 (1), p.147-147, Article 147

2017

Volltextzugriff (PDF)

Efficacy and Safety of Etanercept Biosimilars Compared With the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study

ACR open rheumatology, 2021-11, Vol.3 (11), p.779-787

2021

Volltextzugriff (PDF)

Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis - data from a German Inception cohort

Pediatric rheumatology online journal, 2023-04, Vol.21 (1), p.31-31, Article 31

2023

Volltextzugriff (PDF)

Medication burden in young adults with juvenile idiopathic arthritis: data from a multicentre observational study

Rheumatic & musculoskeletal diseases open, 2022-10, Vol.8 (2), p.e002520

2022

Volltextzugriff (PDF)

Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis

Rheumatic & musculoskeletal diseases open, 2022-03, Vol.8 (1), p.e002042

2022

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

ThemaArthritis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(57)

Sprache

Erscheinungsjahr

n.n

Thema

Rheumatology
(54)
Life Sciences & Biomedicine
(53)
Science & Technology
(53)
Humans
(35)
Child
(33)
Pediatrics
(33)
Patients
(32)
Adolescent
(27)
Arthritis, Juvenile - Drug Therapy
(25)
Male
(25)
Female
(24)
Juvenile Idiopathic Arthritis
(23)
Treatment Outcome
(18)
Antirheumatic Agents - Therapeutic Use
(17)
Child, Preschool
(17)
Drug Therapy
(15)
Disease
(12)
Arthritis, Juvenile - Diagnosis
(11)
Etanercept
(11)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry

Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry

Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany

Baricitinib in therapy of COPA syndrome in a 15-year-old girl

Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry

Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohort

The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON)

Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still's disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity

Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis

Outcome of adult patients with JIA treated with the biosimilar Benepali ® : results of the biologic register JuMBO

Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial

Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry

Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study

Fluorescence optical imaging in pediatric patients with inflammatory and non-inflammatory joint diseases: a comparative study with ultrasonography

Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review

S2k guidelines for the treatment of psoriasis in children and adolescents – Short version part 2

Protocols on classification, monitoring and therapy in children's rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis

Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany

Level and correlates of physical activity among children and adolescents with juvenile idiopathic arthritis compared to controls: results from a German nationwide prospective observational cohort study

Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial

Fluorescence optical imaging and musculoskeletal ultrasonography in juvenile idiopathic polyarticular disease before and during antirheumatic treatment - a multicenter non-interventional diagnostic evaluation

Efficacy and Safety of Etanercept Biosimilars Compared With the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study

Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis - data from a German Inception cohort

Medication burden in young adults with juvenile idiopathic arthritis: data from a multicentre observational study

Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis

Aktive Filter

Suchergebnisse filtern